What is Septerna, Inc.'s R&D?

Septerna, Inc. (SEPN) reported R&D of $29.54M in Q1 2026.

How has Septerna, Inc.'s R&D changed year-over-year?

Septerna, Inc.'s R&D increased by 53.3% year-over-year, from $19.27M to $29.54M.

Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.

Septerna, Inc. SEPN R&D

R&D at other companies

AmgenAMGN

$1.72B+15.7%

Stoke Therapeutics, Inc.STOK

$39.67M+21.4%

Nurix Therapeutics, Inc.NRIX

$84.14M+20.8%

Rapport Therapeutics, Inc.RAPP

$32.72M+67.2%

PrecigenPGEN

$5.64M-46.2%

Catalyst PharmaceuticalCPRX

$2.66M-31.5%

Other financials

Income statement

See full

Revenue$26.5M+12,011%

Operating income-$13.3M+48.7%

Net income-$8.6M+59.8%

EPS (diluted)-$0.19+61.2%

Balance sheet

See full

Cash & equivalents$71.6M-65.9%

Total debt$23.1M-7.7%

Total equity$378.5M+195%

Total assets$569.7M+31.3%

Cash flow

See full

Operating cash flow-$25.6M-9.8%

CapEx$832.0K+118%

Free cash flow-$26.5M-11.5%

Valuation

See full

Market cap$1.65B+319%

Enterprise value$1.6B+1,325%

P/S22.8×-379×

Profitability

See full

Operating margin-77.1%-38.4pp

Net margin-49.9%-24.9pp

FCF margin467.9%+243pp

Returns & leverage

See full

Return on equity-12.2%—

Debt / equity0.1×—

Current ratio4.7×-27.5×

Where this comes from

Reported directly by Septerna, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: Septerna, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Septerna, Inc.'s r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Septerna, Inc.'s R&D?: Septerna, Inc. (SEPN) reported R&D of $29.54M in Q1 2026.
How has Septerna, Inc.'s R&D changed year-over-year?: Septerna, Inc.'s R&D increased by 53.3% year-over-year, from $19.27M to $29.54M.
What does R&D mean?: Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.